ArticleCureus2026
A Rare Case of Squamous Cell Carcinoma of the Gallbladder Presenting as a Bleeding Colonic Mass.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Gallbladder carcinoma (GBC) is the most common malignancy of the biliary tract, with adenocarcinoma being the predominant histological subtype. Squamous cell carcinoma (SCC) is rare, accounting for approximately 1%-4% of gallbladder carcinomas, and is characterized by aggressive local invasion and poor prognosis. We report a 53-year-old man with a one-year history of recurrent painless lower gastrointestinal bleeding and a six-month history of progressive constipation, abdominal bloating, and unintentional weight loss. His bleeding had previously been attributed to a known grade 4 hemorrhoid. Colonoscopy revealed a friable, bleeding mass at the hepatic flexure in addition to non-bleeding grade 4 hemorrhoids. Histopathological examination of the colonic biopsy demonstrated moderately differentiated SCC. Immunohistochemistry was positive for cytokeratin 7 (CK7) and p63, and negative for cytokeratin 20 (CK20), hepatocyte paraffin 1 (HepPar-1), and alpha-fetoprotein (AFP). Contrast-enhanced computed tomography (CT) subsequently demonstrated a large heterogeneous gallbladder mass with direct invasion of the adjacent liver and hepatic flexure, rendering the tumor unresectable. The integrated clinicoradiological and pathological findings supported a diagnosis of locally advanced gallbladder SCC with direct extension into the colon. The patient received gemcitabine and oxaliplatin chemotherapy, followed by endoscopic retrograde cholangiopancreatography (ERCP) with biliary stent placement and palliative surgical management for persistent lower gastrointestinal bleeding. This case highlights the diagnostic challenge posed by gallbladder SCC presenting as a bleeding colonic mass. Squamous carcinoma identified in a colonic lesion should prompt consideration of an extra-colonic primary, with immunohistochemistry interpreted alongside clinical and radiological findings. Persistent gastrointestinal bleeding warrants thorough evaluation even when an apparent anorectal source is present.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.